Literature DB >> 18697211

Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.

Charles Nicaise1, Deborah Prozzi, Eric Viaene, Christophe Moreno, Thierry Gustot, Eric Quertinmont, Pieter Demetter, Valérie Suain, Philippe Goffin, Jacques Devière, Pascal Hols.   

Abstract

UNLABELLED: Hyperammonemia is a common complication of acute and chronic liver diseases. Often accompanied with side effects, therapeutic interventions such as antibiotics or lactulose are generally targeted to decrease the intestinal production and absorption of ammonia. In this study, we aimed to modulate hyperammonemia in three rodent models by administration of wild-type Lactobacillus plantarum, a genetically engineered ammonia hyperconsuming strain, and a strain deficient for the ammonia transporter. Wild-type and metabolically engineered L. plantarum strains were administered in ornithine transcarbamoylase-deficient Sparse-fur mice, a model of constitutive hyperammonemia, in a carbon tetrachloride rat model of chronic liver insufficiency and in a thioacetamide-induced acute liver failure mice model. Constitutive hyperammonemia in Sparse-fur mice and hyperammonemia in a rat model of chronic hepatic insufficiency were efficiently decreased by Lactobacillus administration. In a murine thioacetamide-induced model of acute liver failure, administration of probiotics significantly increased survival and decreased blood and fecal ammonia. The ammonia hyperconsuming strain exhibited a beneficial effect at a lower dose than its wild-type counterpart. Improved survival in the acute liver failure mice model was associated with lower blood ammonia levels but also with a decrease of astrocyte swelling in the brain cortex. Modulation of ammonia was abolished after administration of the strain deficient in the ammonium transporter. Intestinal pH was clearly lowered for all strains and no changes in gut flora were observed.
CONCLUSION: Hyperammonemia in constitutive model or after acute or chronic induced liver failure can be controlled by the administration of L. plantarum with a significant effect on survival. The mechanism involved in this ammonia decrease implicates direct ammonia consumption in the gut.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697211     DOI: 10.1002/hep.22445

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

Review 2.  Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling.

Authors:  Silvia C Resta
Journal:  J Physiol       Date:  2009-07-13       Impact factor: 5.182

Review 3.  Gut microbiota-related complications in cirrhosis.

Authors:  Isabel Gómez-Hurtado; José Such; Yolanda Sanz; Rubén Francés
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Enhancement of hepatic autophagy increases ureagenesis and protects against hyperammonemia.

Authors:  Leandro R Soria; Gabriella Allegri; Dominique Melck; Nunzia Pastore; Patrizia Annunziata; Debora Paris; Elena Polishchuk; Edoardo Nusco; Beat Thöny; Andrea Motta; Johannes Häberle; Andrea Ballabio; Nicola Brunetti-Pierri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

5.  Peripheral ammonia as a mediator of methamphetamine neurotoxicity.

Authors:  Laura E Halpin; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

6.  Engineering the gut microbiota to treat hyperammonemia.

Authors:  Ting-Chin David Shen; Lindsey Albenberg; Kyle Bittinger; Christel Chehoud; Ying-Yu Chen; Colleen A Judge; Lillian Chau; Josephine Ni; Michael Sheng; Andrew Lin; Benjamin J Wilkins; Elizabeth L Buza; James D Lewis; Yevgeny Daikhin; Ilana Nissim; Marc Yudkoff; Frederic D Bushman; Gary D Wu
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

7.  Understanding the physiology of Lactobacillus plantarum at zero growth.

Authors:  Philippe Goffin; Bert van de Bunt; Marco Giovane; Johan H J Leveau; Sachie Höppener-Ogawa; Bas Teusink; Jeroen Hugenholtz
Journal:  Mol Syst Biol       Date:  2010-09-21       Impact factor: 11.429

8.  Peripheral ammonia and blood brain barrier structure and function after methamphetamine.

Authors:  Nicole A Northrop; Laura E Halpin; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

Review 9.  The human microbiome is a source of therapeutic drug targets.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Curr Opin Chem Biol       Date:  2013-05-13       Impact factor: 8.822

10.  Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.

Authors:  Laura E Halpin; Nicole A Northrop; Bryan K Yamamoto
Journal:  Neuropsychopharmacology       Date:  2013-10-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.